Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The host gut mucosal immune interface is a complex biological system comprising the intestinal epithelium, the overlying mucus layer, and the underlying gut-associated lymphoid tissue (GALT). Its primary biological function is to maintain intestinal homeostasis by facilitating a delicate balance between immune tolerance toward commensal microbiota and dietary antigens, and robust protective immunity against enteric pathogens (Mowat & Agace, 2014, Nature Reviews Immunology). This interface acts as a physical and chemical barrier, utilizing tight junctions and antimicrobial peptides to prevent the translocation of luminal contents into the systemic circulation (Turner, 2009, Nature Reviews Immunology). In disease states such as inflammatory bowel disease (IBD) or celiac disease, this interface becomes dysregulated, leading to chronic inflammation, increased permeability, and barrier breakdown (Okumura & Takeda, 2017, Nature Reviews Immunology). While not a single molecular target, it serves as the critical site of action for numerous therapeutic agents, including monoclonal antibodies that block leukocyte migration or neutralize inflammatory cytokines (Danese et al., 2015, Gut). Understanding the cellular and molecular interactions at this interface is essential for developing precision medicines that restore immune equilibrium without compromising systemic host defense.
Modulation of leukocyte trafficking, neutralization of pro-inflammatory cytokines, and maintenance of epithelial barrier integrity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host gut mucosal immune interface (GMI).